As of July, 80% of U.S. physicians had conducted virtual consultations. Those who hadn't worry mainly about quality of care, liability...

Hospital patient volumes have rebounded in August after major Covid related dips, with outpatient and surgery down 7-8% and emergency...

Proteus, the “smart pill” unicorn, once valued at $1.5 billion, is acquired by Otsuka for $15 million. Digital Therapeutics have a great...

In post-Covid, health professionals want more support and interactions from representatives, through a mix of virtual and in-person. This...

Remote patient monitoring has dramatically increased with Covid-19 outbreak. For this to last, the technology must be easy to use by...

To reduce backlog of elective surgeries, hospitals such as Johns Hopkins are prioritizing procedures based on surgical risks, capacity...

Covid-19 pandemic has created roller-coaster situations for Pharma and MedTech companies. For post-covid commercial restart, life science...

Usage of Biosimilars has increased significantly in Europe, while usage in the US has been lagging behind. Now, Biosimilars are finally...

Beyond the hype and quick adaptation to Covid, the future of telemedicine depends on payers' willingness to reimburse it post-pandemic,...

While orthopedic or cardiac procedures increased after April low, the pandemic continues; MedTech companies need to adapt to business...

In post-Covid, emergency medicine is moving out of emergency department, with virtual front door triage or post-discharge telehealth...

Telemedicine use soared during Covid oubreak. Telesurgery could follow, with fast and reliable 5G network connections, and increased...

How can Pharma and MedTech boost sales teams in post-covid: Adjust sales and resource expectations around scenarios Re-work incentives...

The Covid-19 outbreak, with countless of cases and half a million deaths to date, has brought a massive impact to patients, families, and...

Shift to digital only and remote interactions was/is the only available option during the pandemic. I expect the new normal to be...

Launching in pandemic time requires bold moves, such as those taken by Esperion, Horizon, Eisai or Clarus: - remote interactions with...

“We are thrilled to welcome Laurent to our Board of Directors,” said Juha Yrjänheikki, CEO of Aurealis Therapeutics. “His vast commercial...

Orthopedic, Cardiac, Neuro surgeons expect 3/4 of elective procedures returning by September, survey says. This should help MedTech...

Following initial surge due to Covid-19, patients continue seeing doctors remotely because it's more convenient and faster than in...

Restarting elective procedures ? Medicare/Medicaid has released guidance: - continue preventing the spread of the virus - reduce...